BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29374691)

  • 1. Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer.
    Tanadini-Lang S; Bogowicz M; Veit-Haibach P; Huellner M; Pauli C; Shukla V; Guckenberger M; Riesterer O
    Anticancer Res; 2018 Feb; 38(2):685-690. PubMed ID: 29374691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approach.
    Huellner MW; Pauli C; Mattei A; Ross S; Diebold J; Vosbeck J; Allgayer B; Strobel K; Veit-Haibach P
    Invest Radiol; 2014 Sep; 49(9):571-8. PubMed ID: 24710202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study.
    Łuczyńska E; Heinze-Paluchowska S; Blecharz P; Jereczek-Fossa B; Petralia G; Bellomi M; Stelmach A
    Med Sci Monit; 2015 Jan; 21():153-62. PubMed ID: 25582437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancer.
    Huellner MW; Mattei A; Ross S; Butea-Bocu M; Vosbeck J; Pauli C; Diebold J; Seifert B; Strobel K; Veit-Haibach P
    Clin Imaging; 2014; 38(6):850-7. PubMed ID: 25168905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomography-based Radiomics for Risk Stratification in Prostate Cancer.
    Osman SOS; Leijenaar RTH; Cole AJ; Lyons CA; Hounsell AR; Prise KM; O'Sullivan JM; Lambin P; McGarry CK; Jain S
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):448-456. PubMed ID: 31254658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of perfusion CT parameters, microvessl density and VEGF expression in differentiation of benign and malignant prostate tumours.
    Luczynska E; Gasinska A; Blecharz P; Stelmach A; Jereczek-Fossa BA; Reinfuss M
    Pol J Pathol; 2014 Oct; 65(3):229-36. PubMed ID: 25372421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of radiomic features in CT perfusion maps.
    Bogowicz M; Riesterer O; Bundschuh RA; Veit-Haibach P; Hüllner M; Studer G; Stieb S; Glatz S; Pruschy M; Guckenberger M; Tanadini-Lang S
    Phys Med Biol; 2016 Dec; 61(24):8736-8749. PubMed ID: 27893446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
    Reiner CS; Roessle M; Thiesler T; Eberli D; Klotz E; Frauenfelder T; Sulser T; Moch H; Alkadhi H
    Invest Radiol; 2013 Apr; 48(4):183-91. PubMed ID: 23328912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion MDCT of prostate cancer: correlation of perfusion CT parameters and immunohistochemical markers of angiogenesis.
    Osimani M; Bellini D; Di Cristofano C; Palleschi G; Petrozza V; Carbone A; Laghi A
    AJR Am J Roentgenol; 2012 Nov; 199(5):1042-8. PubMed ID: 23096177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    Woo S; Kim SY; Cho JY; Kim SH
    AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer.
    Singanamalli A; Rusu M; Sparks RE; Shih NN; Ziober A; Wang LP; Tomaszewski J; Rosen M; Feldman M; Madabhushi A
    J Magn Reson Imaging; 2016 Jan; 43(1):149-58. PubMed ID: 26110513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell cancer of hypopharynx and larynx - evaluation of metastatic nodal disease based on computed tomography perfusion studies.
    Trojanowska A; Trojanowski P; Bisdas S; Staśkiewicz G; Drop A; Klatka J; Bobek-Billewicz B
    Eur J Radiol; 2012 May; 81(5):1034-9. PubMed ID: 21324623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
    Wu CJ; Zhang YD; Bao ML; Li H; Wang XN; Liu XS; Shi HB
    AJR Am J Roentgenol; 2017 Nov; 209(5):1081-1087. PubMed ID: 28834443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology.
    Ives EP; Burke MA; Edmonds PR; Gomella LG; Halpern EJ
    Clin Prostate Cancer; 2005 Sep; 4(2):109-12. PubMed ID: 16197611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.
    Leisser A; Pruscha K; Ubl P; Wadsak W; Mayerhöfer M; Mitterhauser M; Hacker M; Kramer G; Shariat S; Karanikas G; Hartenbach M; Haug AR
    Prostate; 2015 Nov; 75(15):1760-7. PubMed ID: 26282590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tumor grade and angiogenesis in colorectal cancer: whole-volume perfusion CT.
    Sun H; Xu Y; Yang Q; Wang W
    Acad Radiol; 2014 Jun; 21(6):750-7. PubMed ID: 24809317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of prostate cancer with integrated CT-perfusion using a sector-wise approach.
    Ferrari M; Huellner M; Pauli C; Seifert B; Danuser H; Veit-Haibach P; Mattei A
    Turk J Urol; 2017 Jun; 43(2):152-157. PubMed ID: 28717538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FN13762 murine breast cancer: region-by-region correlation of first-pass perfusion CT indexes with histologic vascular parameters.
    Park CM; Goo JM; Lee HJ; Kim MA; Kim HC; Kim KG; Lee CH; Im JG
    Radiology; 2009 Jun; 251(3):721-30. PubMed ID: 19474375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy.
    Lim CS; McInnes MDF; Flood TA; Breau RH; Morash C; Thornhill RE; Schieda N
    AJR Am J Roentgenol; 2017 May; 208(5):1037-1044. PubMed ID: 28267359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.